Bellerophon Therapeutics (NASDAQ:BLPH) Stock Crosses Below Two Hundred Day Moving Average – What’s Next?

Bellerophon Therapeutics, Inc. (NASDAQ:BLPH)’s stock price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.04 and traded as low as $0.01. Bellerophon Therapeutics shares last traded at $0.01, with a volume of 7,027 shares.

Wall Street Analysts Forecast Growth

Separately, StockNews.com began coverage on Bellerophon Therapeutics in a report on Thursday. They set a “hold” rating on the stock.

Bellerophon Therapeutics Trading Down 25.5 %

The company has a market cap of $146,796.00, a PE ratio of -0.01 and a beta of 0.74. The stock has a fifty day simple moving average of $0.03 and a two-hundred day simple moving average of $0.04.

Bellerophon Therapeutics Dividend Announcement

The business also recently announced a dividend, which was paid on Wednesday, December 18th. Shareholders of record on Friday, December 20th were issued a dividend of $0.019 per share. This represents a yield of 117.8%. The ex-dividend date of this dividend was Thursday, December 19th.

About Bellerophon Therapeutics

Bellerophon Therapeutics, Inc, a clinical-stage therapeutics company, focuses on the development of products for the treatment of cardiopulmonary diseases in the United States. Its primary product is INOpulse, a proprietary pulsatile nitric oxide delivery platform for the treatment of pulmonary hypertension.